Task Force 1: Preparticipation screening and diagnosis of cardiovascular disease in athletes

This publication has 24 references indexed in Scilit:

• Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy
  Circulation, 2005
• Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy
  Journal of the American College of Cardiology, 2004
• Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography
  Heart, 2004
• Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
  Circulation, 2003
• American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
  Journal of the American College of Cardiology, 2003
• American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
  European Heart Journal, 2003
• Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy
  New England Journal of Medicine, 2000
• Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients
  Journal of the American College of Cardiology, 1995
• Preparticipation cardiovascular evaluation of the competitive athlete: Perspectives from the 30-year Italian experience
  The American Journal of Cardiology, 1995
• The Upper Limit of Physiologic Cardiac Hypertrophy in Highly Trained Elite Athletes
  New England Journal of Medicine, 1991